0001209191-15-018168.txt : 20150224
0001209191-15-018168.hdr.sgml : 20150224
20150224213855
ACCESSION NUMBER: 0001209191-15-018168
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150220
FILED AS OF DATE: 20150224
DATE AS OF CHANGE: 20150224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNIVERSAL BIOSENSORS INC
CENTRAL INDEX KEY: 0001279695
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980424072
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 1 CORPORATE AVENUE
STREET 2: ROWVILLE
CITY: VICTORIA
STATE: C3
ZIP: 3178
BUSINESS PHONE: 613-9213-9000
MAIL ADDRESS:
STREET 1: 1 CORPORATE AVENUE
STREET 2: ROWVILLE
CITY: VICTORIA
STATE: C3
ZIP: 3178
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wright Paul
CENTRAL INDEX KEY: 0001514822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52607
FILM NUMBER: 15645748
MAIL ADDRESS:
STREET 1: 1 CORPORATE AVENUE
CITY: ROWVILLE, VICTORIA
STATE: C3
ZIP: 3178
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-02-20
0
0001279695
UNIVERSAL BIOSENSORS INC
UBI
0001514822
Wright Paul
1 CORPORATE AVENUE
ROWVILLE
VICTORIA
C3
3178
AUSTRALIA
1
1
0
0
Chief Executive Officer
Common stock
2015-02-20
4
A
0
337428
101819.82
A
337428
I
By Chatsworth Trust
Common stock
44666
I
By Macqarie Super Fund Manager
Common stock
142105
I
By P K W Super Fund
Common stock
2957
D
Stock Option (Right to Buy)
0.00
2020-12-11
Common Stock
60000
60000
D
Stock Option (Right to Buy)
0.00
2019-11-12
Common Stock
37500
37500
D
Stock Option (Right to Buy)
1.38
2018-02-23
Common Stock
2300000
2300000
D
The prices reported are stated in Australian dollars.
The reported securities are held in trust for the benefit of the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The reported securities are held by the Macquarie Super Fund Manager in a pooled superannuation fund for the account of the Reporting Person.
The reported securities are held by the Macquarie Super Fund Manager in trust and for the account of the Reporting Person.
On December 12, 2013, the board of directors approved the grant of these options subject to shareholder approval. Such shareholder approval was received on June 12, 2014. The stock options vest and become exercisable in three equal tranches om 12/31/14, 12/31/15 and 12/31/16.
On November 13, 2012, the board of directors approved the grant of these options subject to shareholder approval. Such shareholder approval was received on May 16, 2013. The stock options vest and become exercisable in three equal tranches om 12/31/13, 12/31/14 and 12/31/15.
1,400,000 options vest in equal traunches over three years subject to continued employment at the time of vesting. 500,000 of the options vested upon the company entering into a material partnership/licensing agreement with Siemens Healthcare Diagnostics, Inc. on September 9, 2011. 400,000 options vest upon CE marketing or first regulatory approval in the United States of the final test to which the partnership/licensing arranagement relates, subject to continued employment at the time of vesting.
/s/ Cameron Billingsley, attorney-in-fact
2015-02-24